MVT
Desconocido
EPITARGET: Targets and biomarkers for antiepileptogenesis
MICROVITAE TECHNOLOGIES SAS
participó en un
FP7:
Epilepsy is a devastating condition affecting over 50 million people worldwide. This multidisciplinary project is focused on the process lea...
Financiado
Financiado
* No se disponen de datos de la empresa actual.